Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 12, 2016 09:00 ET | Source: Endologix

Endologix to Report Second Quarter 2016 Financial Results on August 2, 2016

IRVINE, Calif., July 12, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the...
June 09, 2016 09:33 ET | Source: Endologix

Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy

IRVINE, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the...
June 03, 2016 09:00 ET | Source: Endologix

Endologix to Present at Jefferies Healthcare Conference

IRVINE, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the...
May 26, 2016 09:00 ET | Source: Endologix

Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study

IRVINE, Calif., May 26, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from...
May 16, 2016 09:00 ET | Source: Endologix

Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study

IRVINE, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
May 09, 2016 16:05 ET | Source: Endologix

Endologix Reports Results for the First Quarter 2016

IRVINE, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the...
April 29, 2016 09:00 ET | Source: Endologix

Endologix to Participate in Two Investor Conferences in May

IRVINE, Calif., April 29, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
April 28, 2016 12:15 ET | Source: Endologix

Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium

IRVINE, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first data presentation...
April 27, 2016 11:00 ET | Source: Endologix

Positive Nellix Clinical Data from the Global Registry and Treatment of Iliac Aneurysm Studies Presented at the 38th Annual Charing Cross Symposium

IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of positive...
April 19, 2016 16:00 ET | Source: Endologix

Endologix to Report First Quarter 2016 Financial Results on May 9, 2016

IRVINE, Calif., April 19, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the...